X

See our webpage about the GA-map® product platform

Visit page

Skip to content

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us

News

Genetic Analysis announces terms of the previously announced subsequent offering to shareholders of up to appr. NOK 9 million

2023-11-30

Presentation of GA-map® by Genetic Analysis sparks great interest at xMAP® Connect EMEA in Amsterdam

2023-11-16

Genetic Analysis AS participates at Medica 13-16. November 2023

2023-11-15

Genetic Analysis announces placement of directed share issue of appr. NOK 10 mill, intention to conduct subsequent offering to shareholders, non-binding letter of intent for further investment as well as updated milestones

2023-11-022023-11-02

GA private placement letter of intent milestones

Genetic Analysis: Launch of GA-map® Discovery – A microbiome profiling offering for Research Customers

2023-10-252023-10-24

GA-map new product Discovery launch

New Luminex whitepaper describes how the GA-map® Dysbiosis Test utilizes xMAP® technology for microbiome profiling

2023-10-13

Genetic Analysis: Development project initiated for a new companion diagnostic test

2023-10-12

Chinese pharma and medtech visit Genetic Analysis

2023-10-11

Stay updated and subscribe to GA investor newsletters, financial reports and press releases

2023-09-21

Genetic Analysis presents at Sedermeradagen 2023 in Stockholm

2023-05-25

Post navigation

Older posts

Page1 Page2 … Page6 Next →

Genetic Analysis AS is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Contact

Phone: +47 48 32 16 10
E-mail: info@genetic-analysis.com
Address: Genetic Analysis AS, Ulvenveien 80B
0581 Oslo, Norway

Open Google Maps

Connect

Navigate

© 2023 Genetic Analysis

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us